Related Articles
PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis
Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathway
Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon
Protection against Adriamycin® cytotoxicity and inhibition of DNA topoisomerase II activity by 3,4-dihydroxybenzoic acid
DEVELOPMENT AND CHARACTERIZATION OF AN ADRIAMYCIN-RESISTANT SW480 HUMAN COLON ADENOCARCINOMA CELL-LINE